167 related articles for article (PubMed ID: 38566153)
1. Anchoring super-enhancer-driven oncogenic lncRNAs for anti-tumor therapy in hepatocellular carcinoma.
Yuan XQ; Zhou N; Wang JP; Yang XZ; Wang S; Zhang CY; Li GC; Peng L
Mol Ther; 2023 Jun; 31(6):1756-1774. PubMed ID: 36461633
[TBL] [Abstract][Full Text] [Related]
2. Super-enhancers: Implications in gastric cancer.
Huang Y; Huo Y; Huang L; Zhang L; Zheng Y; Zhang N; Yang M
Mutat Res Rev Mutat Res; 2024; 793():108489. PubMed ID: 38355091
[TBL] [Abstract][Full Text] [Related]
3. Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets.
Liu S; Dai W; Jin B; Jiang F; Huang H; Hou W; Lan J; Jin Y; Peng W; Pan J
Mol Cancer; 2024 Jun; 23(1):122. PubMed ID: 38844984
[TBL] [Abstract][Full Text] [Related]
4. Super-enhancer interactomes from single cells link clustering and transcription.
Le DJ; Hafner A; Gaddam S; Wang KC; Boettiger AN
bioRxiv; 2024 May; ():. PubMed ID: 38766104
[TBL] [Abstract][Full Text] [Related]
5. Super enhancer lncRNAs: a novel hallmark in cancer.
Song P; Han R; Yang F
Cell Commun Signal; 2024 Apr; 22(1):207. PubMed ID: 38566153
[TBL] [Abstract][Full Text] [Related]
6. Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer.
Ropri AS; DeVaux RS; Eng J; Chittur SV; Herschkowitz JI
Breast Cancer Res; 2021 Oct; 23(1):101. PubMed ID: 34717732
[TBL] [Abstract][Full Text] [Related]
7. SELER: a database of super-enhancer-associated lncRNA- directed transcriptional regulation in human cancers.
Guo ZW; Xie C; Li K; Zhai XM; Cai GX; Yang XX; Wu YS
Database (Oxford); 2019 Jan; 2019():. PubMed ID: 30806704
[TBL] [Abstract][Full Text] [Related]
8. [Research progress of super enhancer in cancer].
Wu ZQ; Mi ZY
Yi Chuan; 2019 Jan; 41(1):41-51. PubMed ID: 30686784
[TBL] [Abstract][Full Text] [Related]
9. Characterization of super-enhancer-associated functional lncRNAs acting as ceRNAs in ESCC.
Wang QY; Peng L; Chen Y; Liao LD; Chen JX; Li M; Li YY; Qian FC; Zhang YX; Wang F; Li CQ; Lin DC; Xu LY; Li EM
Mol Oncol; 2020 Sep; 14(9):2203-2230. PubMed ID: 32460441
[TBL] [Abstract][Full Text] [Related]
10. Super-enhancers complexes zoom in transcription in cancer.
Wang M; Chen Q; Wang S; Xie H; Liu J; Huang R; Xiang Y; Jiang Y; Tian D; Bian E
J Exp Clin Cancer Res; 2023 Jul; 42(1):183. PubMed ID: 37501079
[TBL] [Abstract][Full Text] [Related]
11. Phase IIa Study of PLX2853 in Gynecologic Cancers With Known ARID1A Mutation and Phase Ib/IIa Study of PLX2853/Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer.
Duska LR; Zamarin D; Hamilton E; Oza A; Fleming G; Spira A; Yeku OO; Richardson DL; Walling J; Inokuchi K; Matusow B; Bollag G; Swisher EM
JCO Precis Oncol; 2023 Sep; 7():e2300235. PubMed ID: 37797273
[TBL] [Abstract][Full Text] [Related]
12. Super Enhancer-Regulated LncRNA LINC01089 Induces Alternative Splicing of DIAPH3 to Drive Hepatocellular Carcinoma Metastasis.
Su T; Zhang N; Wang T; Zeng J; Li W; Han L; Yang M
Cancer Res; 2023 Dec; 83(24):4080-4094. PubMed ID: 37756562
[TBL] [Abstract][Full Text] [Related]
13. METTL3-stabilized super enhancers-lncRNA SUCLG2-AS1 mediates the formation of a long-range chromatin loop between enhancers and promoters of SOX2 in metastasis and radiosensitivity of nasopharyngeal carcinoma.
Hu X; Wu J; Feng Y; Ma H; Zhang E; Zhang C; Sun Q; Wang T; Ge Y; Zong D; Chen W; He X
Clin Transl Med; 2023 Sep; 13(9):e1361. PubMed ID: 37658588
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
